Project Grant HT94252410856
Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $250K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
- This federal Project Grant award for $7,700,740.00 was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Ohio State University. The funding supports a 4-year research project titled "CONSEQUENCES OF BRAIN INJURY ON GLIA-NEURON DYNAMICS, NEUROPATHOLOGY, AND NEUROPSYCHIATRIC ILLNESS" aimed at investigating the effects of brain injury on glial-neuronal interactions, neuropathology, and neuropsychiatric conditions. The...
- The Ohio State University received a $248,237 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund a 3-year project from July 1, 2023 to June 30, 2026 to research and address traumatic brain injuries among law enforcement officers. No additional details about specific products or services to be delivered under this award were provided. The Military Medical Research and Development program supports basic,...
- The Defense Health Agency awarded a $1,479,970.00 Project Grant to The Ohio State University (OSU) under the Military Medical Research and Development (CFDA 12.420) program. This grant, titled "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)", will fund advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The project will run from July 15, 2025 to July 14, 2029. As a prominent research institution, OSU will leverage its...
- The Defense Health Agency awarded a $512,751.00 Project Grant to The Ohio State University for the period from July 1, 2023 to June 30, 2026. The grant was provided under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the American public through innovative and impactful research, and to investigate medical solutions for the battlefield. The grant funds will...
- This $2,976,672 Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at The Ohio State University to examine the efficacy of short-term intensive PTSD treatment on psychological and cognitive impairment symptoms. The performance period runs from September 1, 2025 to August 31, 2029. The research aims to develop innovative diagnostic tools, therapeutic interventions, and clinical practice guidelines...
- The Defense Health Agency awarded a $1,489,045 Project Grant to The Ohio State University under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)", aims to conduct advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The project, with a performance period from July 15, 2025 to July 14, 2029, will focus on developing novel diagnostic...
- This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $551,250.00 to The Ohio State University to support research on PPP2R1B IN DEDIFFERENTIATED LIPOSARCOMA. The project will be performed in Columbus, OH and run from Sep 30, 2023 through Sep 29, 2026. The Ohio State University has a history of conducting biomedical research and providing clinical trial coordination services to federal agencies like the National...
- The U.S. Defense Health Agency awarded a $1,465,907 Project Grant to The Ohio State University on July 15, 2025 under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)", supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The project, with a planned completion date of July 14, 2029, will focus on developing innovative diagnostic...
- This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,181,250.00 to The Ohio State University to conduct research on the use of MIF inhibition and glucocorticoid therapeutics as a synergistic treatment to promote neuronal survival in traumatic retinal injury. The research aims to develop novel therapies for this type of injury, which is of particular relevance to military personnel. The...
- The Ohio State University was awarded a $1,574,999 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a novel approach for targeting metastatic breast cancer. The project will run from June 15, 2025 to June 14, 2028 and focuses on the role of the SLIT2 protein in metastatic breast cancer. As a prominent public research university, The Ohio State University will leverage its multidisciplinary expertise to...